Covered recipient · General Payments record
TILAK JOSHI
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$1,049.93
- Reported across 22 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $558.69 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | $249.98 | 2 |
| SANOFI-AVENTIS U.S. LLC | $118.73 | 1 |
| Amgen Inc. | $76.15 | 3 |
| Novo Nordisk AS | $44.20 | 2 |
| Smith & Nephew, Inc. | $31.53 | 1 |
| ABBVIE INC. | $24.85 | 1 |
| Lilly USA, LLC | $13.25 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.85 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104013670 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $124.99 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146974173 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $124.99 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147024660 | CMS |
| Amgen Inc. | $21.32 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115775824 | CMS |
| Amgen Inc. | $26.28 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117592025 | CMS |
| Amgen Inc. | $28.55 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117592027 | CMS |
| Lilly USA, LLC | $13.25 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135496348 | CMS |
| Novo Nordisk Inc | $22.16 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097308326 | CMS |
| Novo Nordisk Inc | $22.04 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097184060 | CMS |
| SANOFI-AVENTIS U.S. LLC | $118.73 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139797972 | CMS |
| Smith+Nephew, Inc. | $31.53 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149608829 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.